LMC Diabetes is an industry leader, providing Phase I-IV clinical trial services in nine sites, across three Canadian provinces. Together with Manna Research who primarily focuses on primary care studies provides Sponsors, CRO’s & ARO’s access to one of the largest fully owned and operated clinical research site networks within Canada at thirteen sites across four provinces.
LMC Diabetes primary focus is diabetes, obesity, metabolic, and cardiovascular disease. Manna Research is a combination of diseases but focuses 30% of their efforts in diabetes and metabolic disease.
Principal Investigators at each site follow a uniform set of SOPs, conforming to ICH, GCP and Health Canada Division 5 guidelines. Internal training, fellowship and certification are all provided.
Founded by Dr. Ronnie Aronson in 1997, LMC Diabetes & Endocrinology is Canada’s leading national diabetes, endocrinology and metabolic disease practice, serving Canadian patients with diabetes and other general endocrinology concerns. LMC’s national practice is led by 35 endocrinologists in nine clinics in Ontario, Alberta and Quebec. LMC’s 160+ member team of healthcare professionals provide multidisciplinary community-based care to Canadian diabetics and endocrinology patients with a focus on education, service excellence and meeting their comprehensive medical needs. The team also operates full-service pharmacies and an online platform for diabetes education, material and supplies at http://www.diabetessource.ca/. LMC stands among global leaders in early through late stage endocrinology and metabolic disease clinical research, with nine Canadian sites and a dedicated Phase I research facility in Toronto. LMC has consistently been recognized among Canada’s Best Workplaces® by the Great Place to Work Institute.